The kallikreins: old proteases with new clinical potentials

Manfred Schmitt; Thomas Renné; Andreas Scorilas

doi:10.1160/TH13-07-0583

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2013; 110(03): 396-398
DOI: 10.1160/TH13-07-0583

Theme Issue Editorial

Schattauer GmbH

The kallikreins: old proteases with new clinical potentials

Manfred Schmitt

¹Clinical Research Unit, Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich, Germany

,

Thomas Renné

²Department of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden

³Division of Clinical Chemistry, University Hospital Eppendorf, Hamburg, Germany;

,

Andreas Scorilas

⁴Department of Biochemistry and Molecular Biology, University of Athens, Athens, Greece

› Author Affiliations

Abstract

Full Text

References

References
1 Schmitt M, Magdolen V. Using kallikrein-related peptidases (KLK) as novel cancer biomarkers. Thromb Haemost 2009; 101: 222-224.
2 Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 2004; 04: 876-890.
3 Clements JA. Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?. Biol Chem 2008; 389: 1447-1454.
4 Kontos CK, Scorilas A. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers. Clin Chem Lab Med 2012; 50: 1877-1891.
5 Lundwall A. Old genes and new genes: The evolution of the kallikrein locus. Thromb Haemost 2013; 110: 469-475.
6 Vickers AJ, Roobol MJ, Lilja H. Screening for prostate cancer: early detection or overdetection?. Annu Rev Med 2012; 63: 161-170.
7 Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 2007; 53: 1423-1432.
8 Pathak M, Wong SS, Dreveny I. et al. Structure of plasma and tissue kallikreins. Thromb Haemost 2013; 110: 423-433.
9 Ekholm IE, Brattsand M, Egelrud T. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process?. J Invest Dermatol 2000; 114: 56-63.
10 Fischer J, Meyer-Hoffert U. Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options. Thromb Haemost 2013; 110: 442-449.
11 Sotiropoulou G, Pampalakis G. Targeting the kallikrein-related peptidases for drug development. Trends Pharmacol Sci 2012; 33: 623-634.
12 Kontos CK, Mavridis K, Talieri M. et al. Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: Mechanistic and clinical aspects. Thromb Haemost 2013; 110: 450-457.
13 Dorn J, Bayani J, Yousef GM. et al. Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies. Thromb Haemost 2013; 110: 408-422.
14 Thorek DLJ, Evans MJ, Carlsson SV. et al. Prostate specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Thromb Haemost 2013; 110: 484-492.
15 Waeckel L, Potier L, Richer C. et al. Pathophysiology of genetic deficiency in tissue kallikrein activity in mouse and man. Thromb Haemost 2013; 110: 476-483.
16 Fink E, Bhoola KD, Snyman C. et al. Cellular expression of plasma prekallikrein in human tissues. Biol Chem 2007; 388: 957-963.
17 Marcondes S, Antunes E. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system. Curr Med Chem Cardiovasc Hematol Agents 2005; 03: 33-44.
18 Björkqvist J, Jämsä A, Renné T. Plasma kallikrein: the bradykinin-producing enzyme. Thromb Haemost 2013; 110: 399-407.
19 Feener EP, Zhou Q, Fickweiler W. Role of plasma kallikrein in diabetes and metabolism. Thromb Haemost 2013; 110: 434-441.
20 Pruneau D, Belichard P, Sahel JA. et al. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy. Curr Opin Investig Drugs 2010; 11: 507-514.
21 de Maat S, van Dooremalen S, de Groot PG. et al. A nanobody-based method for tracking factor XII activation in plasma. Thromb Haemost 2013; 110: 458-468.